Wed, Mar 4, 2015, 2:52 PM EST - U.S. Markets close in 1 hr 8 mins


% | $
Quotes you view appear here for quick access.

Vical Incorporated Message Board

  • gofordna gofordna Mar 10, 2013 1:10 PM Flag

    On the radar

    nice to wake up on a Sunday and see that Motley Fool featured Vical's 31% price move, triggered by Vijay's presentation on Wednesday. I like free PR like this. Let's see if we've finally punched through the $3.75 wall that this MB has seen in this movie before. IMO we'll continue moving higher this month. Time will tell.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • time will tell. At some point in the next two years we will see that decimal point move to the right.

      • 1 Reply to samlhop
      • If A-7 is approved, I think VICL will be bought, and I think it is worth much more to BMY than medarex was, even with MDX1106 in the pipeline. I think $2.4 would be the lowest tolerable price if A-7 hits, double that? We know that their basic technology works and is marketable, that is what Oncept means. A-7 working would mean that they have a viable platform for human gene therapy, as well as one worth while drug. They must have tons of propitiatory IP that is worth a mountain of cash and future revenues. All this hinges on A-7 working due to its proof of principle quality. I have a feeling that A-7 will beat both Yervoy and MDX1106 on several metrics, the only thing I can think of that would make this not true would be some kind of fraud, the last we have heard is that the event threshold has not yet been met.

    • roth capital conference presentation on 3/19

1.01+0.02(+1.81%)2:48 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.